Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Jul 27 - Aug 1
EMT inhibitor-1 induces GSK3-β–mediated degradation of the Hippo transducer TAZ
InChi: InChI=1S/C23H28FN2O5P/c1-16-2-4-17(5-3-16)14-26-13-11-22(23(26)27)25-12-10-20(21(24)15-25)18-6-8-19(9-7-18)31-32(28
and 3) Amylin (8-37) elicits a significant alteration of in vivo lipid metabolism
) lower MAP over 24 hours in normotensive wild-type mice but not in KCa3
RG-13022 inhibits not only EGF-induced growth but also growth stimulated by insulin
(-)-Cevimeline hydrochloride hemihydrate Catalog No.:M34745-C EMT inhibitor-1 induces GSK3-β–mediated degradation( ) Cevimeline hydrochloride hemihydrate (( ) SNI 2011), a novel muscarinic receptor agonist, is a candidate therapeutic drug for xerostomia in Sjogren's syndrome. IC50 value: Target: mAChR The general pharmacol. properties of this drug on the gastrointestinal, urinary, and reproductive systems and other tissues were investigated in mice, rats, guinea pigs, rabbits, and dogs. The in vitro metab. of SNI 2011 was also evaluated with rat and dog liver